Skip to main content
. 2021 Jan 8;32(5):817–824. doi: 10.1093/icvts/ivaa323

Table 1:

Baseline patient characteristics

Variables Survivors (n = 73) Non-survivors (n = 100) P-value
Age (years) 65.4 (±11.0) 65.3 (±10.5) 0.933
Female gender 27 (36.9) 54 (54.0) 0.031
BMI (kg/m2) 27.5 (±4.8) 28.2 (±5.4) 0.392
Diabetes mellitus 20 (27.4) 42 (42.0) 0.035
Arterial hypertension 56 (76.7) 80 (80.0) 0.282
Pulmonary hypertension 14 (19.2) 22 (22.0) 0.510
COPD 2 (2.7) 7 (7.0) 0.306
Smoker 26 (35.6) 29 (29.0) 0.494
Hyperlipidaemia 39 (53.4) 50 (50.0) 0.789
Peripheral vascular disease 16 (21.9) 37 (37.0) 0.021
Neurological dysfunction 10 (13.7) 11 (11.0) 0.662
Preoperative creatinine (mg/dl) 1.2 (±1.1) 1.2 (±0.5) 0.917
Preoperative GFR (ml/min) 82.6 (±39.9) 72.5 (±32.7) 0.080
Preoperative dialysis 1 (1.4) 4 (4.0) 0.337
Elective surgery 41 (56.2) 51 (51.0) 0.501
Urgent surgery 19 (26.0) 22 (22.0) 0.538
Emergency surgery 13 (17.8) 27 (27.0) 0.157
Left main stenosis 8 (10.9) 11 (11.0) 0.683
Prior PCI 9 (12.3) 17 (17.0) 0.394
Prior MI 14 (19.2) 21 (21.0) 0.706
 MI <48 h 4 (5.5) 2 (2.0) 0.683
 MI 2–21 days 3 (4.1) 3 (3.0) 0.237
 MI 22–90 days 2 (2.7) 5 (5.0) 0.425
 MI >91 days 5 (6.8) 11 (11.0) 0.311
Prior heart surgery 12 (24.5) 37 (37) 0.003
Months since prior heart surgery 57 (7–141) 48 (9–102) 0.633
Logistic EuroSCORE (%) 10.9 (±13.3) 17.5 (±18.1) 0.009
Active endocarditis 6 (8.2) 14 (14.0) 0.240
Type A aortic dissection 0 (0) 4 (4.0) 0.139

Values are represented as number (percentage), mean (±standard deviation) or median (interquartile range). P values < 0.05 in bold are statistically significant.

BMI: body mass index; COPD: chronic obstructive pulmonary disease; GFR: glomerular filtration rate; LVEF: left ventricular ejection fraction; MI: myocardial infarction; PCI: percutaneous coronary intervention.